Cross-platform urine metabolomics of experimental hyperglycemia in type 2 diabetes

Temmerman, Liesbet, De Livera, Alysha M., Bowne, Jairus, Sheedy, John R., Callahan, Damien L., Nahid, Amsha, De Souza, David P., Schoofs, Liliane, Tull, Dedreia L., McConville, Malcolm J., Roessner, Ute and Wentworth, John M. 2012, Cross-platform urine metabolomics of experimental hyperglycemia in type 2 diabetes, Journal of diabetes & metabolism, no. S6, pp. 1-7, doi: 10.4172/2155-6156.S6-002.

Attached Files
Name Description MIMEType Size Downloads

Title Cross-platform urine metabolomics of experimental hyperglycemia in type 2 diabetes
Author(s) Temmerman, Liesbet
De Livera, Alysha M.
Bowne, Jairus
Sheedy, John R.
Callahan, Damien L.ORCID iD for Callahan, Damien L.
Nahid, Amsha
De Souza, David P.
Schoofs, Liliane
Tull, Dedreia L.
McConville, Malcolm J.
Roessner, Ute
Wentworth, John M.
Journal name Journal of diabetes & metabolism
Issue number S6
Start page 1
End page 7
Total pages 7
Publisher OMICS Publishing Group
Place of publication Los Angeles, Calif.
Publication date 2012
ISSN 2155-6156
Keyword(s) Metabolomics
Summary Hyperglycemia causes diabetic nephropathy, a condition for which there are no specific diagnostic markers thatpredict progression to renal failure. Here we describe a multiplatform metabolomic analysis of urine from individualswith type 2 diabetes, collected before and immediately following experimental hyperglycemia. We used targetednuclear magnetic resonance spectroscopy (NMR), liquid chromatography - mass spectrometry (LC-MS) and gaschromatography - MS (GC-MS) to identify markers of hyperglycemia. Following optimization of data normalisation andstatistical analysis, we identified a reproducible NMR and LC-MS based urine signature of hyperglycemia. Significantincreases of alanine, alloisoleucine, isoleucine, leucine, N-isovaleroylglycine, valine, choline, lactate and taurine anddecreases of arginine, gamma-aminobutyric acid, hippurate, suberate and N-acetylglutamate were observed. GC-MSanalysis identified a number of metabolites differentially present in post-glucose versus baseline urine, but these could not be identified using current metabolite libraries. This analysis is an important first step towards identifying biomarkers of early-stage diabetic nephropathy.
Language eng
DOI 10.4172/2155-6156.S6-002
Field of Research 030105 Instrumental Methods (excl Immunological and Bioassay Methods)
110199 Medical Biochemistry and Metabolomics not elsewhere classified
Socio Economic Objective 920104 Diabetes
ERA Research output type C Journal article
Copyright notice ©2012, OMICS Publishing Group
Persistent URL

Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 195 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Thu, 05 May 2016, 15:19:29 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact